SV2003000843A - Utilizacion de cromanos lea 34992-sv - Google Patents

Utilizacion de cromanos lea 34992-sv

Info

Publication number
SV2003000843A
SV2003000843A SV2002000843A SV2002000843A SV2003000843A SV 2003000843 A SV2003000843 A SV 2003000843A SV 2002000843 A SV2002000843 A SV 2002000843A SV 2002000843 A SV2002000843 A SV 2002000843A SV 2003000843 A SV2003000843 A SV 2003000843A
Authority
SV
El Salvador
Prior art keywords
chromans
read
hydraphs
benzisotiazol
isopropoxi
Prior art date
Application number
SV2002000843A
Other languages
English (en)
Inventor
Thomas Fahrig
Irene Gerlach
Ervin Horvath
Reinhard Jork
Frank Mauler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV2003000843A publication Critical patent/SV2003000843A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DEL 1,1-DIOXIDO DE 2-[4-({[(2R)-8-ISOPROPOXI-CROMAN-2-IL]METIL}AMINO)BUTIL]-1,2-BENZISOTIAZOL-3(2H)-ONA, DE SUS SALES, HIDRATOS Y/O SOLVATOS FISIOLOGICAMENTE ACEPTABLES, EN ESPECIAL DE SUS CLORHIDRATOS PARA LA PREPARACION DE UN MEDICAMENTO PARA LA PROFILAXIS Y/O TRATAMIENTO DE LA ENFERMEDAD DE PARKINSON.
SV2002000843A 2001-01-16 2002-01-15 Utilizacion de cromanos lea 34992-sv SV2003000843A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10101917A DE10101917A1 (de) 2001-01-16 2001-01-16 Verwendung von Chromanen

Publications (1)

Publication Number Publication Date
SV2003000843A true SV2003000843A (es) 2003-01-13

Family

ID=7670832

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2002000843A SV2003000843A (es) 2001-01-16 2002-01-15 Utilizacion de cromanos lea 34992-sv

Country Status (17)

Country Link
US (1) US20020177616A1 (es)
EP (1) EP1353670A2 (es)
JP (1) JP2004520342A (es)
KR (1) KR20040025885A (es)
CN (1) CN1529596A (es)
AR (1) AR032070A1 (es)
BR (1) BR0206475A (es)
CA (1) CA2436811A1 (es)
DE (1) DE10101917A1 (es)
GT (1) GT200200002A (es)
IL (1) IL156839A0 (es)
MX (1) MXPA03006333A (es)
PE (1) PE20020841A1 (es)
PL (1) PL362869A1 (es)
SV (1) SV2003000843A (es)
UY (1) UY27123A1 (es)
WO (1) WO2002055078A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60215203T2 (de) 2001-09-12 2007-10-18 Merck Patent Gmbh VERWENDUNG VON AMINOMETHYL CHROMANEN ZUR BEHANDLUNG DER NEBENWIRKUNGEN VON NEUROLEPTIkA
GT200600078A (es) * 2005-02-17 2007-04-12 Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados
US9066903B2 (en) * 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
DE19754573A1 (de) * 1997-12-09 1999-06-10 Bayer Ag Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma

Also Published As

Publication number Publication date
MXPA03006333A (es) 2004-04-20
CA2436811A1 (en) 2002-07-18
CN1529596A (zh) 2004-09-15
PE20020841A1 (es) 2002-10-02
AR032070A1 (es) 2003-10-22
WO2002055078A3 (de) 2003-03-13
WO2002055078A2 (de) 2002-07-18
JP2004520342A (ja) 2004-07-08
US20020177616A1 (en) 2002-11-28
PL362869A1 (en) 2004-11-02
BR0206475A (pt) 2003-12-30
GT200200002A (es) 2002-09-02
KR20040025885A (ko) 2004-03-26
UY27123A1 (es) 2002-08-30
DE10101917A1 (de) 2002-07-18
IL156839A0 (en) 2004-02-08
EP1353670A2 (de) 2003-10-22

Similar Documents

Publication Publication Date Title
HUP0303656A2 (hu) Bruton-féle tirozin kináz modulátorai és Bruton-féle tirozin kináz intermedierek, és eljárások azonosításukra és alkalmazásuk oszteoporózis és rokon betegségek kezelésére és prevenciójára
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
DE60205481D1 (de) Furan and thiophen derivate die menschliche peroxisome proliferator aktivierte receptoren aktivieren
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
TW200736255A (en) 5-(Substituted)-pyrazolopiperidines
ATE300306T1 (de) Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung
GB0117645D0 (en) Therapeutic stratergies for prevention and treatment of alzheimers disease
ATE473967T1 (de) Aminopyrazolderivate als gsk-3-inhibitoren
BR0207883A (pt) Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv
BR0112674A (pt) Inibidores n-[5-[[[5-alquil-2-oxazolil]metil] tio]-2tiazolil]carboxamida de quinases dependentes de ciclina
CY1107616T1 (el) Καινοτομος χρηση της 2-[5-(4-φθοροφαινυλο)-3-πυριδυλομεθυλαμινομεθυλο]-χρωμανης και των φυσιολογικα αποδεκτων αλατων της
DE50202959D1 (de) Inlay für eine Knie-Endoprothese
SV2003000843A (es) Utilizacion de cromanos lea 34992-sv
RU2007147957A (ru) Комбинация производных пиримидиламинобензамида и иматиниба для лечения или профилактики пролиферативных заболеваний
CL2004001068A1 (es) Compuestos derivados de 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina; procedimientos de preparacion; composicion farmaceutica que los contiene y su uso en la elaboracion de un medicamento util para el tratamiento de la enfermedad de alzheimer.
ECSP045242A (es) Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faríngea
AU2003232805A8 (en) Pharmaceutical active substance combination and the use thereof
BR0001191B1 (pt) artigo pessoal portátil e descartável, contendo um produto para cuidado do corpo.
DOP2002000326A (es) Utilizacion de cromanos
HK1054198A1 (en) Novel use of (R)-(-)-2-Ä5-(4-fluorophenyl)-3-pyridylmethylaminomethylÜ-chromane and its physiologically acceptable salts.
AR039177A1 (es) Derivados de morfolina, antagonistas de ccr3.
HUP0401324A2 (hu) 4-[Fenil-(piperidinil)-amino]-benzamid-származékok és alkalmazásuk fájdalom, szorongás vagy gasztrointesztinális zavarok kezelésére
HUP0401115A3 (en) 4-(benzylideneamino)-3-(methylsulfanyl)-4h-[1,2,4]triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies, process for their preparation and pharmaceutical compositions ...
HUP0402654A2 (hu) 2-[(2'-Halogén-3',5'-dialkoxi-fenil)-imino]-imidazolidin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
CY1105868T1 (el) Χρηση υποκατεστημενων αμινομεθυλ χρωμανων στην θepαπεια των παρενepγειων των νευροληπτικων

Legal Events

Date Code Title Description
FD Lapse